Krishna Yeshwant's most recent trade in Verve Therapeutics Inc was a trade of 42,200 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 42,200 | 42,200 | - | - | Stock Option (right to buy) | |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 136,139 | 136,139 | - | - | Stock Option (right to buy) | |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.00 per share. | 01 Dec 2023 | 1,800,000 | 1,800,000 | - | 10 | 18,000,000 | Common Stock |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 26,642 | 26,642 | - | - | Stock Option (right to buy) | |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 04 Nov 2022 | 48,583 | 6,108,442 | - | 0 | Common Stock | |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.12 per share. | 04 Nov 2022 | 47,690 | 4,260,940 | - | 31.1 | 1,484,017 | Common Stock |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.99 per share. | 04 Nov 2022 | 650 | 4,260,290 | - | 32.0 | 20,794 | Common Stock |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.90 per share. | 04 Nov 2022 | 243 | 4,260,047 | - | 32.9 | 7,995 | Common Stock |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 02 Nov 2022 | 49,569 | 6,157,025 | - | 0 | Common Stock | |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 02 Nov 2022 | 28,651 | 6,206,594 | - | 0 | Common Stock | |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.14 per share. | 02 Nov 2022 | 25,534 | 4,310,385 | - | 33.1 | 846,156 | Common Stock |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.32 per share. | 02 Nov 2022 | 22,279 | 4,335,919 | - | 32.3 | 719,957 | Common Stock |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 36.28 per share. | 02 Nov 2022 | 10,372 | 4,367,128 | - | 36.3 | 376,282 | Common Stock |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 34.78 per share. | 02 Nov 2022 | 9,350 | 4,377,500 | - | 34.8 | 325,150 | Common Stock |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 36.78 per share. | 02 Nov 2022 | 8,930 | 4,358,198 | - | 36.8 | 328,401 | Common Stock |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.84 per share. | 02 Nov 2022 | 1,755 | 4,308,630 | - | 33.8 | 59,384 | Common Stock |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Oct 2022 | 53,697 | 6,267,208 | - | 0 | Common Stock | |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Oct 2022 | 31,963 | 6,235,245 | - | 0 | Common Stock | |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 36.69 per share. | 31 Oct 2022 | 29,326 | 4,389,487 | - | 36.7 | 1,075,906 | Common Stock |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 37.91 per share. | 31 Oct 2022 | 23,732 | 4,448,777 | - | 37.9 | 899,588 | Common Stock |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 38.94 per share. | 31 Oct 2022 | 23,275 | 4,425,502 | - | 38.9 | 906,403 | Common Stock |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 40.16 per share. | 31 Oct 2022 | 6,601 | 4,418,901 | - | 40.2 | 265,076 | Common Stock |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 37.82 per share. | 31 Oct 2022 | 2,377 | 4,387,110 | - | 37.8 | 89,901 | Common Stock |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 38.64 per share. | 31 Oct 2022 | 260 | 4,386,850 | - | 38.6 | 10,046 | Common Stock |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 40.65 per share. | 31 Oct 2022 | 88 | 4,418,813 | - | 40.6 | 3,577 | Common Stock |
| EQRx Inc | Krishna Yeshwant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 101,010 | 101,010 | - | - | Stock Option (Right to Buy) | |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 15,500 | 15,500 | - | - | Stock Option (right to buy) | |
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | 21 Jun 2021 | 58,528,428 | 0 | - | - | Series A Preferred Stock | ||
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | 21 Jun 2021 | 37,308,792 | 0 | - | - | Series A-2 Preferred Stock | ||
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | 21 Jun 2021 | 6,320,905 | 6,320,905 | - | - | Common Stock | ||
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | 21 Jun 2021 | 4,104,416 | 0 | - | - | Series B Preferred Stock | ||
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | 21 Jun 2021 | 4,029,244 | 4,029,244 | - | - | Common Stock | ||
| Verve Therapeutics Inc | Krishna Yeshwant | Director, Ten Percent Owner | 21 Jun 2021 | 443,265 | 4,472,509 | - | - | Common Stock |